Advertisement

GI & Endoscopy

The European Commission reversed its decision and will allow Takeda to retain the rights to an inflammatory bowel disease candidate it was supposed to divest as part of its 2018 acquisition of Shire.

Advertisement

A negative screening colonoscopy led to reduced colorectal cancer incidence and mortality rates for up to 17.4 years, according to a study published in the Annals of Internal Medicine and reported on in MedPage Today.

Advertisement